A phase II, pharmacokinetic, and biological correlative study of oblimersen sodium and docetaxel in patients with hormone-refractory prostate cancer (Q46493707)
scientific article published in May 2005
Language:
Current Data About A phase II, pharmacokinetic, and biological correlative study of oblimersen sodium and docetaxel in patients with hormone-refractory prostate cancer
(P31) (Q13442814)
(P248)
(P698) 15897586
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/15897586

(P304) 3854-3861
(P248)
(P698) 15897586
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/15897586

(P407) (Q1860)

(P433) 10
(P248)
(P698) 15897586
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/15897586

(P478) 11
(P248)
(P698) 15897586
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/15897586

(P577) Sunday, May 1, 2005
(P248)
(P698) 15897586
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/15897586

(P921) (Q181600)

(Q420436)
(P887)

(Q181257)
(P887)

(Q323936)
(P887)

(P1433) (Q332253)
(P248)
(P698) 15897586
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/15897586

(P1476) "A phase II, pharmacokinetic, and biological correlative study of oblimersen sodium and docetaxel in patients with hormone-refractory prostate cancer" (language: en)
(P248)
(P698) 15897586
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/15897586

(P2093) Anthony W Tolcher
(P1545) 1
(P248)
(P698) 15897586
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/15897586

Kim Chi
(P1545) 2
(P248)
(P698) 15897586
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/15897586

John Kuhn
(P1545) 3
(P248)
(P698) 15897586
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/15897586

Martin Gleave
(P1545) 4
(P248)
(P698) 15897586
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/15897586

Amita Patnaik
(P1545) 5
(P248)
(P698) 15897586
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/15897586

Chris Takimoto
(P1545) 6
(P248)
(P698) 15897586
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/15897586

Garry Schwartz
(P1545) 7
(P248)
(P698) 15897586
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/15897586

Ian Thompson
(P1545) 8
(P248)
(P698) 15897586
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/15897586

Kristin Berg
(P1545) 9
(P248)
(P698) 15897586
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/15897586

Susan D'Aloisio
(P1545) 10
(P248)
(P698) 15897586
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/15897586

Nevin Murray
(P1545) 11
(P248)
(P698) 15897586
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/15897586

Stanley R Frankel
(P1545) 12
(P248)
(P698) 15897586
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/15897586

Elzbieta Izbicka
(P1545) 13
(P248)
(P698) 15897586
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/15897586

Eric Rowinsky
(P1545) 14
(P248)
(P698) 15897586
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/15897586

other details
description scientific article published in May 2005

External Links
(P356) 10.1158/1078-0432.CCR-04-2145
(P698) 15897586
(P5875) 7843113